Lynx Investment Advisory’s Pfizer PFE Stock Holding History

Lynx Investment Advisory’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.44M	Buy	59,638 +5,347	+10%	+$140K	0.47%	56
2026 Q1	$1.52M	Buy	54,291 +5,246	+11%	+$140K	0.73%	32
2025 Q4	$1.22M	Sell	49,045 -379	-0.8%	-$9.56K	0.67%	32
2025 Q3	$1.26M	Sell	49,424 -791	-2%	-$19.5K	0.75%	30
2025 Q2	$1.22M	Buy	50,215 +2,433	+5%	+$56.7K	0.8%	31
2025 Q1	$1.21M	Buy	47,782 +16,621	+53%	+$435K	0.81%	29
2024 Q4	$827K	Buy	31,161 +3,866	+14%	+$105K	0.56%	42
2024 Q3	$790K	Sell	27,295 -161	-0.6%	-$4.7K	0.57%	42
2024 Q2	$768K	Buy	+27,456	New	+$756K	0.57%	38

Other funds holding PFE

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

SLAM

Swiss Life Asset Management Zurich $24.1B AUM 38.82% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

CWP

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Lynx Investment Advisory's PFE Position: Q2 2026 in Review

Lynx Investment Advisory increased its Pfizer (PFE) stake by 9.8% in Q2 2026, buying an estimated $140K and bringing the position to 59,638 shares worth $1.44M. The position accounts for 0.47% of the portfolio, ranked #56.

Lynx Investment Advisory first reported a position in PFE in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.52M in Q1 2026. 1,338 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Lynx Investment Advisory held 59,638 shares of Pfizer worth $1.44M as of Q2 2026.
Lynx Investment Advisory bought 5,347 Pfizer shares in Q2 2026, an estimated $140K.
Pfizer made up 0.47% of Lynx Investment Advisory's portfolio in Q2 2026, its #56 holding.
Lynx Investment Advisory first reported a position in Pfizer in Q2 2024 and has held it in 9 quarters since.
Lynx Investment Advisory's Pfizer position peaked at $1.52M in Q1 2026.
1,338 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Lynx Investment Advisory's 13F filing for Q2 2026, filed 27 Jul 2026.